Varicella and herpes zoster. Part 2: Therapy and prevention;Varizellen und Herpes zoster : Teil 2: Therapie und Prävention

Medizinische Klinik

Volumn 105, Issue 6, 2010, Pages 399-403

  Wittek, Miriam ^a   Doerr, Hans Wilhelm ^a   Allwinn, Regina ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Pregnancy; Prevention; Risk groups; Therapy; Varicella zoster virus infection

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; CHICKENPOX VACCINE; FAMCICLOVIR; FOSCARNET; IMMUNOGLOBULIN; LIVE VACCINE; VALACICLOVIR;

AGE DISTRIBUTION; CHICKENPOX; EXPOSURE; GERMANY; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; NEWBORN INFECTION; PASSIVE IMMUNIZATION; POSTHERPETIC NEURALGIA; PREGNANT WOMAN; PRIMARY PREVENTION; RASH; REVIEW; SYMPTOM; TREATMENT INDICATION; VIRUS REPLICATION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNIZATION, PASSIVE; IMMUNIZATION, SECONDARY; INFANT; INFANT, NEWBORN; NEURALGIA, POSTHERPETIC; OPPORTUNISTIC INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; YOUNG ADULT;

HERPES ZOSTER; HUMAN HERPESVIRUS 3;

EID: 77954580588     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-010-1071-1     Document Type: Review

References (22)

1. M. Takahashi Y. Okuno T. Otsuko, et al. 1975 Development of a live attenuated varicella vaccine Biken J 18 25 33 1:STN:280:DyaE2M3gsVOjtg%3D%3D 167707
2. Robert Koch Institut. 2009 Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch Institut/Stand Juli 2009 Epidemiologisches Bulletin 32 328 336
3. M. Brisson W.J. Edmunds N.J. Gay 2003 Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV J Med Virol 70 Suppl1 S31 S37 10.1002/jmv.10317 12627484 (Pubitemid 36368842)
4. M.N. Oxman M.J. Levin G.R. Johnson, et al. 2005 A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults N Engl J Med 352 2271 2284 10.1056/NEJMoa051016 1:CAS:528:DC%2BD2MXksl2ltro%3D 15930418 (Pubitemid 40740551)
5. Robert Koch Institut. 2009 Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch Institut/Stand Juli 2009 Epidemiologisches Bulletin 30 279 298
6. W. Kempf P. Meylan S. Gerber, et al. 2007 Swiss recommendations for management of varicella zoster virus infections Swiss Med Wkly 137 239 251 1:STN:280:DC%2BD2szktlGjsg%3D%3D 17557214 (Pubitemid 46918007)
7. P.C. Chandra H. Patel H.J. Schiavaello S.L. Briggs 1998 Successful pregnancy outcome after complicated varicella pneumonia Obstet Gynecol 92 680 682 10.1016/S0029-7844(98)00237-3 1:STN:280:DyaK1cvjsFKqsw%3D%3D 9764662 (Pubitemid 28440791)
8. P. Wutzler A. Sauerbrei 2007 Varizellen in der Schwangerschaft und beim Neugeborenen Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 50 237 244 10.1007/s00103-007-0143-8
9. G. Gross H. Schöfer S.W. Wassilew, et al. 2003 Herpes zoster guideline of the German Dermatology Society (DDG) J Clin Virol 26 277 289 10.1016/S1386-6532(03)00005-2 1:STN:280:DC%2BD3s7itlaqug%3D%3D 12637076 (Pubitemid 36294104)
10. Gross G. General aspects of therapy. In: Gross G, Doerr HW, eds. Herpes zoster. Monographs in Virology, vol 26. Basel: Karger, 2006:117-122
11. R. Patel C.V. Paya 1997 Infections in solid-organ transplant recipients Clin Microbiol Rev 10 86 124 1:CAS:528:DyaK2sXotlSqtQ%3D%3D 8993860
12. H.M. Feder Jr D.M. Hoss 2004 Herpes zoster in otherwise healthy children children Pediatr Infect Dis J 23 451 457 10.1097/01.inf.0000126901.88982.32 15131470 (Pubitemid 38621485)
13. J. Colin O. Prisant B. Cochener, et al. 2000 Comparison of efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus Ophthalmology 107 1507 1511 10.1016/S0161-6420(00)00222-0 1:STN:280:DC%2BD3czovVyqtw%3D%3D 10919899
14. S. Tyring R. Engst C. Corriveau, et al. 2001 Famciclovir for ophthalmic zoster: a randomised aciclovir controlled study Br J Ophthalmol 85 576 581 10.1136/bjo.85.5.576 1:STN:280:DC%2BD3M3ntFCltw%3D%3D 11316720 (Pubitemid 32397834)
15. H.H. Balfour Jr 1999 Antiviral drugs N Engl J Med 340 1255 1268 10.1056/NEJM199904223401608 1:CAS:528:DyaK1MXivFWit70%3D 10210711 (Pubitemid 29181648)
16. P. Wutzler H.W. Doerr 1998 Antivirale Therapie des Zosters Dtsch Ärztebl 95 79 81
17. S.D. Shafran S.K. Tyring R. Ashton, et al. 2004 Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults. a randomized, multicenter, double-blind clinical trial J Clin Virol 29 248 253 10.1016/S1386-6532(03)00164-1 1:CAS:528:DC%2BD2cXhslelurs%3D 15018852 (Pubitemid 38281215)
18. S. Wassilew Collaborative Brivudin PHN Study Group 2005 Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study J Eur Acad Dermatol Venereol 19 47 55 10.1111/j.1468-3083. 2004.01119.x 15649191 (Pubitemid 40268140)
19. S.W. Wassilew P. Wutzler 2003 Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study Antiviral Res 59 49 56 10.1016/S0166-3542(03)00065-2 1:CAS:528:DC%2BD3sXkvF2htro%3D 12834860 (Pubitemid 36773890)
20. http://www.rote-liste.de.
21. Lilie HM, Wassilew SW. Antiviral therapy of shingles in dermatology. In: Gross G, Doerr HW, eds. Herpes zoster. Monographs in Virology, vol 26. Basel: Karger, 2006:123-130.
22. Doerr HW, Scholz H. Varizella Zoster Virus (VZV). In: Adam D, Doerr HW, Link H, Lode H, Hrsg. Die Infektiologie. Berlin-Heidelberg: Springer 2004:775-779 (Klinik der Varizellen).